期刊文献+

三维及彩色多普勒超声评估乳腺癌新辅助化疗疗效的价值 被引量:21

Study of three-dimensional and color Doppler ultrasonography in evaluating effect of neoadjuvant chemotherapy for breast cancer
下载PDF
导出
摘要 目的探讨三维超声及彩色多普勒超声在乳腺癌新辅助化疗(NAC)疗效评估中的应用价值。方法收集中南大学湘雅医院经病理学证实并行NAC的乳腺癌患者80例,化疗前后均行临床评估(触诊)、二维及三维超声检查,根据化疗前后乳腺肿块变化与病理评估结果进行比较。结果触诊与病理学评估有效率比较,差异有统计学意义(P<0.05)。二维、三维超声评估与病理学评估有效率比较,差异无统计学意义(P>0.05)。NAC后残存肿瘤二维、三维超声测量体积与病理学测量体积均呈正相关(P<0.05)。有效组NAC前后病灶内血流分级变化数、血流阻力指数比较,差异有统计学意义(P<0.05)。结论三维超声评估NAC疗效与病理学评估具有较高的一致性,良好的临床价值可作为乳腺癌NAC疗效评估的有效方法,乳腺癌病灶超声血流信号的变化有助于乳腺癌NAC疗效判断。 Objective To investigate the clinical application value of three-dimensional ultrasonography and color Doppler ultrasonography in the evaluation of neoadjuvant chemotherapy for breast cancer.Methods In this study 80 breast cancer patients confirmed by pathology who received neoadjuvant chemotherapy in Xiangya Hospital of Central South University were collected.Before and after neoadjuvant chemotherapy,all the patients underwent clinical assessment,two-dimensional(2D)ultrasonographic and three-dimensional(3D)ultrasonographic examinations.The results were compared with the pathological evaluation results according to the changes of breast masses.Results There was a significant difference between clinical assessment and pathological assessment(P<0.05).However,the 2D ultrasonographic and 3D ultrasonographic assessments were not significantly different from the pathological assessment(P>0.05).The maximum diameters of the residual tumors after neoadjuvant chemotherapy by 2D and 3D ultrasound measurement were positively correlated with those by pathological evaluation(P<0.05).In the effective group,the differences in the dropping grade of blood flow grading and reduction of blood flow resistance index before and after chemotherapy had statistical significance(P<0.05).Conclusions 3D ultrasonographic assessment has high consistency with pathological evaluation for curative effect of neoadjuvant chemotherapy.The change of ultrasound blood flow signal in breast cancer masses can be helpful to determine the curative effect of neoadjuvant chemotherapy.
作者 彭翅 肖萤 Chi Peng;Ying Xiao(Xiangya Hospital,Central South University,Changsha,Hunan 410008,China)
出处 《中国现代医学杂志》 CAS 2018年第35期78-82,共5页 China Journal of Modern Medicine
关键词 乳腺肿瘤 超声检查 多普勒 彩色 化学疗法 辅助 breast neoplasms neoadjuvant chemotherapy ultrasonography,Doppler,color
  • 相关文献

参考文献5

二级参考文献15

  • 1罗葆明,欧冰,智慧,曾婕,杨海云.改良超声弹性成像评分标准在乳腺肿块鉴别诊断中的价值[J].现代临床医学生物工程学杂志,2006,12(5):396-398. 被引量:368
  • 2王殊,张嘉庆,乔新民,杨德启,佟富中.新辅助化疗后乳腺癌病理变化31例分析[J].中国妇产科临床杂志,2007,8(4):282-284. 被引量:7
  • 3Smith IC, Hey SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel [ J]. J Clin Oncol,2002,20 : 1456. 被引量:1
  • 4Rajan R, Esteva FJ, Symmans WF. Pathologic changes in breast cancer following neoadjuvant chemotherapy implications for the assessment of response [ J ]. Clin Breast Cancer, 2004,5 ( 3 ) : 235 - 238. 被引量:1
  • 5Feldman L, Hortobagy G, Buzdar A, et al. Pathological assessment of response to induction chemotherapy in breast cancer[ J]. Cancer Res, 1986,46 (5) :2578 - 2581. 被引量:1
  • 6Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging forrevealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy [ J ]. A JR,2002,179 (5) : 1193 - 1199. 被引量:1
  • 7Jos A, vander Hage, Comelis JH, et al. Preoperative chemotherapy in primary operable breast cancer: results from the european organization for research and treatment of caner trial [ J ]. J Clin Oneol, 2001,19:4224 - 4237. 被引量:1
  • 8Moon WK, Im JG, Noh DY, et al. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agentinitial experience[ J]. Radiology ,2000,217 ( 1 ) :240 - 246. 被引量:1
  • 9Lee SW, Choi HY, Baek SY, et al. Role of color and power doppler imaging in differentiating between malignant and benign solid breast masses[ J]. J Clin Ultrasound,2002,30(8 ) :459 -464. 被引量:1
  • 10YUAN Zhu QU Xiang ZHANG Zhong-tao WANG Yu.Neoadjuvant chemotherapy in patients with stages II and III breast cancer[J].Chinese Medical Journal,2009(24):2993-2997. 被引量:15

共引文献31

同被引文献196

引证文献21

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部